Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Eiichiro, Yasutomi"'
Autor:
Yoshihiko Yano, Atsushi Yamamoto, Takuya Mimura, Saeko Kushida, Seiya Hirohata, Seitetsu Yoon, Hirotaka Hirano, Soo Ki Kim, Yuri Hatazawa, Kenji Momose, Hiroki Hayashi, Takuo Kado, Katsuhisa Nishi, Hidenori Tanaka, Takanori Matsuura, Ryutaro Yoshida, Naoki Asaji, Eiichiro Yasutomi, Yuuki Shiomi, Akihiro Minami, Shohei Komatsu, Takumi Fukumoto, Yoshihide Ueda, Yuzo Kodama
Publikováno v:
JGH Open, Vol 7, Iss 7, Pp 476-481 (2023)
Abstract Background and Aim The purpose of this study was to analyze factors associated with the overall survival (OS) of atezolizumab/bevacizumab combination therapy for advanced hepatocellular carcinoma (aHCC). We also assessed the OS of patients w
Externí odkaz:
https://doaj.org/article/91e640e9f6ab4ea98beaae241a32bf33
Autor:
Miki Kawano, Yoshihiko Yano, Atsushi Yamamoto, Eiichiro Yasutomi, Yuta Inoue, Jun Kitadai, Ryutaro Yoshida, Takanori Matsuura, Yuuki Shiomi, Yoshihide Ueda, Yuzo Kodama
Publikováno v:
Diagnostics, Vol 14, Iss 8, p 815 (2024)
Immune checkpoint inhibitor (ICI)-induced liver injury (LI) is a common adverse event, but the clinical characteristics based on the classification of hepatocellular injury and cholestatic types are not fully evaluated. This study aims to analyze ris
Externí odkaz:
https://doaj.org/article/e9709c65e4fb4d12ae4cd493d1f2cfae
Autor:
Yoshihiko Yano, Atsushi Yamamoto, Akihiro Minami, Kenji Momose, Takuya Mimura, Soo Ki Kim, Hiroki Hayashi, Takuo Kado, Hirotaka Hirano, Seiya Hirohata, Seitetsu Yoon, Katsuhisa Nishi, Hiroshi Tei, Hidenori Tanaka, Sachiko Oouchi, Takanori Matsuura, Eiichiro Yasutomi, Yuri Hatazawa, Yuuki Shiomi, Yoshihide Ueda, Yuzo Kodama
Publikováno v:
JGH Open, Vol 6, Iss 6, Pp 427-433 (2022)
Abstract Background and Aim Molecular‐targeted therapies such as sorafenib and lenvatinib have long been used as first‐line treatment for advanced hepatocellular carcinoma (aHCC). However, adverse events or limited therapeutic effects may necessi
Externí odkaz:
https://doaj.org/article/4f7bd6eb83ba480792e82010e9f8e12b
Autor:
Eiichiro Yasutomi, Yoshihiko Yano, Atsushi Yamamoto, Jun Kitadai, Naoki Asaji, Ryutaro Yoshida, Yuri Hatazawa, Takanori Matsuura, Yuuki Shiomi, Yoshihide Ueda, Yuzo Kodama
Publikováno v:
Kanzo. 63:297-300
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bf39563bdf52507f832209d493f80a1b
https://doi.org/10.2957/kanzo.63.297
https://doi.org/10.2957/kanzo.63.297
Autor:
Ryutaro Yoshida, Yoshihiko Yano, Namiko Hoshi, Norihiro Okamoto, Yunlong Sui, Atsushi Yamamoto, Naoki Asaji, Yuuki Shiomi, Eiichiro Yasutomi, Yuri Hatazawa, Hiroki Hayashi, Yoshihide Ueda, Yuzo Kodama
Publikováno v:
Journal of Food Science. 87:2173-2184
Resistant starch (RS) has been reported to improve steatosis as well as obesity. Type 4 resistant starch (RS4), a chemically modified starch, is particularly hard to digest and suggesting higher efficacy. However, because the effects of RS4 on steato
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6dd11feab1f9b3df7a9dfb4ff11c87ee
https://doi.org/10.1111/1750-3841.16146
https://doi.org/10.1111/1750-3841.16146
Autor:
Yoshihiko Yano, Hiroki Hayashi, Arata Sakai, Yuuki Shiomi, Eiichiro Yasutomi, Yoshihide Ueda, Kazutoshi Tobimatsu, Yuzo Kodama, Yuri Hatazawa, Ryutaro Yoshida, Naoki Asaji, Atsushi Yamamoto
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 147:1747-1756
The risk factors and clinical characteristics of ICI-induced immune-mediated hepatotoxicity (IMH) are not fully understood. Thus, the present study sought to clarify the clinical features of IMH. All patients treated with ICIs between September 2014
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::620b0750e6291e15deb284a4e3bbfa1d
https://doi.org/10.1007/s00432-020-03448-8
https://doi.org/10.1007/s00432-020-03448-8
Autor:
Lingling, Kong, Namiko, Hoshi, Daisuke, Watanabe, Yasutaka, Yamada, Eiichiro, Yasutomi, Soichiro, Adachi, Makoto, Ooi, Yunlong, Sui, Ryutaro, Yoshida, Ryohei, Sekimoto, Eri, Tokunaga, Haruka, Miyazaki, Yuna, Ku, Haruka, Takenaka, Tadao, Kunihiro, Jun, Inoue, Zibin, Tian, Yuzo, Kodama
Publikováno v:
Kobe J Med Sci
Daikenchuto (TU-100) is herbal medicine which predominantly contains ginger, Japanese pepper, and ginseng. We investigated whether TU-100 can affect the composition of gut flora and intestinal tumor development using Apc(Min/+) mice, a murine model o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::700a46aef08d29b0b0c1f743a89dbc2a
https://pubmed.ncbi.nlm.nih.gov/33994517
https://pubmed.ncbi.nlm.nih.gov/33994517
Autor:
Yoshihide Ueda, Tomonori Wada, Eiichiro Yasutomi, Yuri Hatazawa, Kimihiro Yamashita, Yuuki Shiomi, Yoshihiko Yano, Masato Kinoshita, Atsushi Yamamoto, Hiroki Hayashi, Yuzo Kodama
Publikováno v:
Clinical journal of gastroenterology. 14(2)
An 80-year old man with myelofibrosis and chronic renal disease was admitted to our hospital because of severe anemia and gastrointestinal bleeding. Although no bleeding was observed by upper or lower endoscopy, contrast-enhanced computed tomography
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87a84a166c790afd80facce01403b661
https://pubmed.ncbi.nlm.nih.gov/33675010
https://pubmed.ncbi.nlm.nih.gov/33675010
Autor:
Yuri Hatazawa, Yoshihiko Yano, Tomoo Itoh, Eiichiro Yasutomi, Yuuki Shiomi, Hidetoshi Gon, Maki Kanzawa, Ryosuke Ishida, Hiroki Hayashi, Yoshihide Ueda, Atsushi Yamamoto, Yuzo Kodama, Satoshi Omiya
Publikováno v:
Clinical journal of gastroenterology. 14(3)
Beta-catenin-activated hepatocellular adenoma is potentially malignant and warrants careful follow-up and surgical resection. Here, we report a 48-year-old man in whom a 55 mm single liver tumor was incidentally detected in the S1 segment. Contrast-e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7b17a1f29a26efad1ad0135e5129da1
https://pubmed.ncbi.nlm.nih.gov/33651269
https://pubmed.ncbi.nlm.nih.gov/33651269
Autor:
Ryutaro Yoshida, Naoki Asaji, Yuuki Shiomi, Yoshihide Ueda, Eiichiro Yasutomi, Yuzo Kodama, Hiroki Hayashi, Yuri Hatazawa, Atsushi Yamamoto, Yoshihiko Yano
Publikováno v:
Clinical journal of gastroenterology. 14(1)
A 72-year-old man underwent transarterial chemoembolization (TACE) for solitary hepatocellular carcinoma (HCC) located on the S6 segment. He had a history of anti-viral therapy for hepatitis C virus and was being treated for diabetes mellitus with in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::505820a8725866bddbd1832407a3d332
https://pubmed.ncbi.nlm.nih.gov/33174157
https://pubmed.ncbi.nlm.nih.gov/33174157